enVVeno Medical Corp Investing Cash Flow
enVVeno Medical Corp (NVNO) reported Investing Cash Flow of $6.44 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-07-30
- enVVeno Medical Corp net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $3.67M, a 29.94% increase year-over-year.
- enVVeno Medical Corp net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $2.77M, a 46.74% decline year-over-year.
- enVVeno Medical Corp net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was $4.18M.
- enVVeno Medical Corp net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $3.65M, a 41.30% decline year-over-year.
- enVVeno Medical Corp net cash provided by (used in) investing activities for fiscal 2025 was $15.86M, a 1087.72% increase from fiscal 2024.
- enVVeno Medical Corp net cash provided by (used in) investing activities for fiscal 2024 was $1.33M.
- enVVeno Medical Corp net cash provided by (used in) investing activities for fiscal 2023 was -$7.87M.
- enVVeno Medical Corp net cash provided by (used in) investing activities for fiscal 2022 was -$34.55M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $6.44M 10-Q · filed 2026-07-30 | $10.62M derived: sum of 3 quarters · filed 2026-07-30 | $14.27M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2026-03-31 | $2.77M 10-Q · filed 2026-05-06 | $6.95M derived: sum of 2 quarters · filed 2026-05-06 | $10.60M derived: sum of 3 quarters · filed 2026-05-06 | $13.43M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-12-31 | $4.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $7.83M derived: sum of 2 quarters · filed 2026-03-26 | $10.65M derived: sum of 3 quarters · filed 2026-07-30 | $15.86M 10-K · filed 2026-03-26 | ||||
| 2025-09-30 | $3.65M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $6.47M derived: sum of 2 quarters · filed 2026-07-30 | $11.67M 10-Q · filed 2025-10-30 | $618.00K derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-06-30 | $2.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $8.02M 10-Q · filed 2026-07-30 | -$3.03M derived: sum of 3 quarters · filed 2026-07-30 | $3.19M derived: sum of 4 quarters · filed 2026-07-30 | ||||
| 2025-03-31 | $5.20M 10-Q · filed 2026-05-06 | -$5.86M derived: sum of 2 quarters · filed 2026-05-06 | $365.00K derived: sum of 3 quarters · filed 2026-05-06 | $4.34M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$11.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$4.84M derived: sum of 2 quarters · filed 2026-03-26 | -$863.00K derived: sum of 3 quarters · filed 2026-03-26 | $1.33M 10-K · filed 2026-03-26 | ||||
| 2024-09-30 | $6.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $10.19M derived: sum of 2 quarters · filed 2025-10-30 | $12.39M 10-Q · filed 2025-10-30 | -$9.75M derived: sum of 4 quarters · filed 2025-10-30 | ||||
| 2024-06-30 | $3.97M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $6.17M 10-Q · filed 2025-07-31 | -$15.97M derived: sum of 3 quarters · filed 2025-07-31 | -$11.53M derived: sum of 4 quarters · filed 2025-07-31 | ||||
| 2024-03-31 | $2.20M 10-Q · filed 2025-04-30 | $2.20M 10-Q · filed 2024-05-08 | -$19.95M derived: sum of 2 quarters · filed 2025-04-30 | -$15.50M derived: sum of 3 quarters · filed 2025-04-30 | -$8.50M derived: sum of 4 quarters · filed 2025-04-30 | |||
| 2023-12-31 | -$22.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$17.70M derived: sum of 2 quarters · filed 2025-02-28 | -$10.70M derived: sum of 3 quarters · filed 2025-02-28 | -$7.87M 10-K · filed 2025-02-28 | ||||
| 2023-09-30 | $4.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $11.45M derived: sum of 2 quarters · filed 2024-10-31 | $14.28M 10-Q · filed 2024-10-31 | $19.79M derived: sum of 4 quarters · filed 2024-10-31 | ||||
| 2023-06-30 | $7.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $9.83M 10-Q · filed 2024-07-31 | $15.35M derived: sum of 3 quarters · filed 2024-07-31 | $13.65M derived: sum of 4 quarters · filed 2024-07-31 | ||||
| 2023-03-31 | $2.83M 10-Q · filed 2024-05-08 | $8.34M derived: sum of 2 quarters · filed 2024-05-08 | $6.65M derived: sum of 3 quarters · filed 2024-05-08 | -$31.66M derived: sum of 4 quarters · filed 2024-05-08 | ||||
| 2022-12-31 | $5.52M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $3.82M derived: sum of 2 quarters · filed 2024-02-29 | -$34.48M derived: sum of 3 quarters · filed 2024-02-29 | -$34.55M 10-K · filed 2024-02-29 | ||||
| 2022-09-30 | -$1.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26 | -$40.00M derived: sum of 2 quarters · filed 2023-10-26 | -$40.07M 10-Q · filed 2023-10-26 | -$40.13M derived: sum of 4 quarters · filed 2023-10-26 | ||||
| 2022-06-30 | -$38.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-31 | -$38.38M 10-Q · filed 2023-07-31 | -$38.44M derived: sum of 3 quarters · filed 2023-07-31 | -$38.59M derived: sum of 4 quarters · filed 2023-07-31 | ||||
| 2022-03-31 | -$69.00K 10-Q · filed 2023-04-28 | -$134.00K derived: sum of 2 quarters · filed 2023-04-28 | -$286.00K derived: sum of 3 quarters · filed 2023-04-28 | -$413.00K derived: sum of 4 quarters · filed 2023-04-28 | ||||
| 2021-12-31 | -$65.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | -$217.00K derived: sum of 2 quarters · filed 2023-03-02 | -$344.00K derived: sum of 3 quarters · filed 2023-03-02 | -$368.00K 10-K · filed 2023-03-02 | -$367.89K 10-K · filed 2022-03-28 | |||
| 2021-09-30 | -$152.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27 | -$279.00K derived: sum of 2 quarters · filed 2022-10-27 | -$303.00K 10-Q · filed 2022-10-27 | -$303.14K 10-Q · filed 2021-11-12 | -$330.54K derived: sum of 4 quarters · filed 2022-10-27 | |||
| 2021-06-30 | -$127.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$151.00K 10-Q · filed 2022-08-03 | -$150.51K 10-Q · filed 2021-08-11 | -$178.54K derived: sum of 3 quarters · filed 2022-08-03 | -$203.50K derived: sum of 4 quarters · filed 2022-08-03 | |||
| 2021-03-31 | -$24.00K 10-Q · filed 2022-04-29 | -$24.03K 10-Q · filed 2021-05-12 | -$51.54K derived: sum of 2 quarters · filed 2022-04-29 | -$76.50K derived: sum of 3 quarters · filed 2022-04-29 | -$198.98K derived: sum of 4 quarters · filed 2022-04-29 | |||
| 2020-12-31 | -$27.54K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | -$52.51K derived: sum of 2 quarters · filed 2022-03-28 | -$174.98K derived: sum of 3 quarters · filed 2022-03-28 | -$180.29K 10-K · filed 2022-03-28 | ||||
| 2020-09-30 | -$24.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$147.44K derived: sum of 2 quarters · filed 2021-11-12 | -$152.75K 10-Q · filed 2021-11-12 | -$165.71K derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | -$122.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | -$127.79K 10-Q · filed 2021-08-11 | -$140.74K derived: sum of 3 quarters · filed 2021-08-11 | -$312.65K derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | -$5.31K 10-Q · filed 2021-05-12 | -$18.27K derived: sum of 2 quarters · filed 2021-05-12 | -$190.17K derived: sum of 3 quarters · filed 2021-05-12 | -$367.40K derived: sum of 4 quarters · filed 2021-05-12 | ||||
| 2019-12-31 | -$12.96K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$184.86K derived: sum of 2 quarters · filed 2021-03-31 | -$362.09K derived: sum of 3 quarters · filed 2021-03-31 | -$363.89K 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | -$171.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-17 | -$349.13K derived: sum of 2 quarters · filed 2020-11-17 | -$350.93K 10-Q · filed 2020-11-17 | -$355.04K derived: sum of 4 quarters · filed 2020-11-17 | ||||
| 2019-06-30 | -$177.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$179.03K 10-Q · filed 2020-08-14 | -$183.13K derived: sum of 3 quarters · filed 2020-08-14 | |||||
| 2019-03-31 | -$1.80K 10-Q · filed 2020-06-08 | -$5.90K derived: sum of 2 quarters · filed 2020-06-08 | ||||||
| 2018-12-31 | -$4.10K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-18 | -$12.42K 10-K · filed 2020-03-18 | ||||||
| 2018-09-30 | -$8.32K 10-Q · filed 2019-10-31 | |||||||
| 2017-12-31 | $69.06K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $192.68K derived: sum of 2 quarters · filed 2019-03-14 | $165.31K 10-K · filed 2019-03-14 | |||||
| 2017-09-30 | $123.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $96.25K 10-Q · filed 2018-11-07 | ||||||
| 2017-06-30 | -$27.36K 10-Q · filed 2018-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |